Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Comment by BlueJays9293on Mar 01, 2024 2:20pm
92 Views
Post# 35909912

RE:What Spectral needs is to annouce their next fiancing ASAP

RE:What Spectral needs is to annouce their next fiancing ASAPThat's not going to work Sherlock, but nice pivot from your childish search warrant fantasy.  Clearly you didn't listen to the conference call that made it very clear that Spectral has enough cash to get them thru the second quarter, and that the July warrants exercise will fund them thru the third quarter.  After that it can be confidently assumed that Baxter/Vantive will do another convertible bond, with no warrant attached, and a 30% premium to the stock price at issuance. 

Nice try, but sadly, you again fell flat on your face.
<< Previous
Bullboard Posts
Next >>